Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation
Nature Cell Biology2015Vol. 17(9), pp. 1193–1204
Citations Over TimeTop 10% of 2015 papers
Maria-Giuseppina Procopio, Csaba László, Dania Al Labban, Dong‐Eun Kim, Pino Bordignon, Seung‐Hee Jo, Sandro Goruppi, Elena Menietti, Paola Ostano, Ugo Ala, Paolo Provero, Wolfram Hoetzenecker, Victor Neel, Witold W. Kilarski, Melody A. Swartz, Cathrin Brisken, Karine Lefort, G. Paolo Dotto
Related Papers
- → Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review(2021)179 cited
- → Research progress on the role of fibroblast activation protein in diagnosis and treatment of cancer(2022)12 cited
- → A ROCK inhibitor promotes keratinocyte survival and paracrine secretion, enhancing establishment of primary human melanocytes and melanocyte–keratinocyte co‐cultures(2019)12 cited
- → Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET(2022)23 cited